Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IO
5201
DELISTED
ION Geophysical Corporation
IO
| $111K | ﹤0.01% |
47,433
-1,874
| -4% | -$4.09K |
|
5202
Phathom Pharmaceuticals
PHAT
$708M
| $110K | ﹤0.01% |
3,332
+2,500
| +300% | +$96.1K |
|
|
PTN
5203
Palatin Technologies
PTN
$13.7M
| $110K | ﹤0.01% |
172
+82
| +91% | +$51K |
|
5204
Neuronetics
STIM
$138M
| $110K | ﹤0.01% |
57,131
+3,041
| +6% | +$6.24K |
|
5205
ProShares Ultra Financials
UYG
$828M
| $110K | ﹤0.01% |
3,779
+334
| +10% | +$9.31K |
|
|
WOW
5206
DELISTED
WideOpenWest
WOW
| $110K | ﹤0.01% |
20,674
+13,811
| +201% | +$77.9K |
|
|
CBMG
5207
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $110K | ﹤0.01% |
7,356
+3,120
| +74% | +$44.6K |
|
|
TECD
5208
DELISTED
Tech Data Corp
TECD
| $110K | ﹤0.01% |
763
-715,489
| -100% | -$98.9M |
|
5209
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$105M
| $109K | ﹤0.01% |
1,471
+774
| +111% | +$49.4K |
|
5210
Distribution Solutions Group
DSGR
$1.6B
| $109K | ﹤0.01% |
6,776
-15,362
| -69% | -$243K |
|
|
GF
5211
New Germany Fund
GF
$182M
| $109K | ﹤0.01% |
7,170
-1,046
| -13% | -$14.3K |
|
|
AE
5212
DELISTED
Adams Resources & Energy Inc
AE
| $109K | ﹤0.01% |
4,090
+516
| +14% | +$13.6K |
|
5213
Arcutis Biotherapeutics
ARQT
$3.36B
| $108K | ﹤0.01% |
3,573
+2,136
| +149% | +$61.7K |
|
5214
Invesco DB Energy Fund
DBE
$90.6M
| $108K | ﹤0.01% |
11,635
-8,766
| -43% | -$74.1K |
|
5215
Financial Institutions
FISI
$816M
| $107K | ﹤0.01% |
5,803
-3,710
| -39% | -$64.7K |
|
|
CIK
5216
Credit Suisse Asset Management Income Fund
CIK
$134M
| $106K | ﹤0.01% |
39,196
-8,761
| -18% | -$22.5K |
|
5217
Retractable Technologies
RVP
$19.8M
| $106K | ﹤0.01% |
15,029
+12,529
| +501% | +$58K |
|
5218
Exicure
XCUR
$10.2M
| $106K | ﹤0.01% |
290
+130
| +81% | +$47.1K |
|
5219
Comstock Resources
CRK
$3.89B
| $105K | ﹤0.01% |
24,103
-19,521
| -45% | -$117K |
|
|
WORX
5220
DELISTED
SCWORX CORP NEW
WORX
| $105K | ﹤0.01% |
+81
| New | +$89.2K |
|
|
LEVL
5221
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $105K | ﹤0.01% |
6,245
+3,440
| +123% | +$59.8K |
|
5222
Beam Global
BEEM
$23.3M
| $104K | ﹤0.01% |
10,415
+3,000
| +40% | +$23.3K |
|
5223
United-Guardian
UG
$32.4M
| $104K | ﹤0.01% |
6,995
-1,224
| -15% | -$18.3K |
|
|
KUST
5224
Kustom Entertainment Inc
KUST
$777K
| – | – |
0
| – | – |
|
5225
Gyre Therapeutics
GYRE
$641M
| $103K | ﹤0.01% |
2,324
+739
| +47% | +$34.7K |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.